Doximity’s AI Surge Drives Strong Earnings | Business and Finance News

Doximity’s Q1 earnings soar with $157M in revenue, up 7% YoY, and $75M in adjusted EBITDA—proving they’re scaling AI without sacrificing margins. Their AI tools, especially Doximity Ask, dominate independent tests for accuracy and safety, now used by 165 top health systems. Workflow adoption is exploding: prescriber usage up 30% YoY, AI note-taking users surged 10x in one month. Real-world validation from the NOHARM study solidifies trust as hospitals demand safer AI. With $700M cash and zero debt, Doximity is doubling down on AI investments, expecting most new contracts to hit revenue in Q3—positioning itself as the essential AI-powered platform for doctors to boost productivity and patient care. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/808d4c2e96b70232